Acetaminophen Tablet, Extended Release
Product Images NDC 62207-892

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Acetaminophen (NDC 62207-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

62207-183-97 (62207 183 97)

Label for Acetaminophen Extended Release Tablets USP, 650 mg. The label includes batch number, manufacturing and expiration dates (placeholders), NDC number 62207-183-97, manufacturer license number, and storage instructions to keep between 20-25°C (68-77°F). It states the pack size as 30 kg and cautions the product is for repacking only. The label also features barcodes and indicates the country of origin as India, with a digital signature by Sujani Pillapalem dated 2021-04-23.*

FDA Label Image

62207-183-35 (62207 183 35)

This text panel for Acetaminophen Extended Release Tablets USP 650 mg includes batch number, manufacturing date, expiration date, NDC number, manufacturing license number, storage instructions (20-25°C), unit count of 3000 tablets, and a caution note indicating the product is for repacking only. The country of origin is India.*

FDA Label Image

62207-183-34 (62207 183 34)

Label for Acetaminophen Extended Release Tablets USP 650 mg. The label includes product details such as batch number, manufacturing and expiration dates (placeholders), NDC number 62207-183-34, and manufacturer license number. It specifies storage instructions to store between 20 - 25 °C and notes the country of origin as India. The package contains 5 units of 3,000 tablets each, with various weights listed as zero, intended for repacking.*

FDA Label Image

62207-183-49 (62207 183 49)

Packaging label for Acetaminophen Extended-Release Tablets USP 650 mg by Granules India Limited. The label states this is a human OTC drug for pain reliever/fever reducer use. The package contains 1000 capsule-shaped bi-layer tablets. The label includes drug facts such as active ingredient, usage, warnings, overdose instructions, inactive ingredients, and manufacturer details with barcode and lot information.*

FDA Label Image

62207-183-51-cont-labl (62207 183 51 Cont Labl)

Label for Acetaminophen Extended-release tablets USP, 650 mg by Granules India Limited. The label states the tablet strength as 650 mg, describes it as a pain reliever and fever reducer, and includes directions, warnings, and usage information for arthritis and minor pain relief. It also shows the NDC code 62207-183-51 and manufacturing details, indicating distribution by Granules USA, Inc.*

FDA Label Image

62207-183-51-crtn-labl (62207 183 51 Crtn Labl)

Acetaminophen Extended-Release tablets USP, 650 mg, oral tablet in capsule-shaped bi-layer form. The packaging states use for muscle aches and pain relief for up to 8 hours with 10 tablets per container. The labeler is Granules India Limited, with distribution by Granules USA, Inc.*

FDA Label Image

62207-183-87 (62207 183 87)

Label for Acetaminophen Extended Release Tablets USP, 650 mg, showing each tablet contains 650 mg acetaminophen. The label includes batch number, manufacturing and expiration dates with placeholders, NDC number 62207-183-87, manufacturing license, storage instructions to keep between 20-25°C (68-77°F), and a caution for repacking only. Country of origin is India.*

FDA Label Image

62207-188-49 (62207 188 49)

Drug Facts label panel for Acetaminophen Extended-release tablets USP 650 mg by Granules India Limited. It details active ingredient, purpose, uses, warnings including liver warnings and allergic reactions, directions for use, inactive ingredients, storage information, and cautions for children. The panel also emphasizes not using with other medicines containing acetaminophen and consulting a doctor if symptoms persist.*

FDA Label Image

62207-188-51-cont-labl (62207 188 51 Cont Labl)

The label for ACETAMINOPHEN extended-release tablets, USP, 650 mg, manufactured by Granules India Limited. The packaging highlights pain relief and fever reduction, specifying 10 capsule-shaped bi-layer caplets per package. The label includes drug facts such as active ingredient, purpose, uses, warnings, and distribution information, with text noting the product is made in India and distributed by Granules USA, Inc.*

FDA Label Image

62207-188-51-crtn-labl (62207 188 51 Crtn Labl)

The packaging label for ACETAMINOPHEN extended-release tablets USP, 650 mg, by Granules India Limited. The carton design features a white and blue color scheme with the product name prominently displayed. It is indicated as a pain reliever and fever reducer for temporary relief of minor arthritis pain. The package contains 10 caplets of 650 mg each, described as capsule-shaped bi-layer tablets. The label includes Drug Facts panels with active ingredient details, uses, warnings, directions, inactive ingredients, manufacturer and distributor information.*

FDA Label Image

Apap-er-10s-label-midol (Apap Er 10s Label Midol)

Packaging label for ACETAMINOPHEN extended-release tablets USP, 650 mg by Granules India Limited. The label indicates the product is for muscle aches and pain relief with 10 capsule-shaped tablets per package. The label includes detailed Drug Facts panels outlining active ingredient, uses, warnings, directions, and inactive ingredients. The product is distributed by Granules USA, Inc., and made in India. The barcode and lot/expiration date areas are visible.*

FDA Label Image

Apap-er-10s-carton-midol (Apap Er 10s Carton Midol)

Acetaminophen extended-release tablets USP, 650 mg, in a carton packaging. The label highlights the product as a pain reliever and fever reducer for muscle aches and pain. It contains 10 caplets, each 650 mg, labeled as capsule-shaped bi-layer tablets. Manufactured by Granules India Limited, with distribution by Granules USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.